These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9613620)

  • 1. Schizophrenia, sensory gating, and nicotinic receptors.
    Adler LE; Olincy A; Waldo M; Harris JG; Griffith J; Stevens K; Flach K; Nagamoto H; Bickford P; Leonard S; Freedman R
    Schizophr Bull; 1998; 24(2):189-202. PubMed ID: 9613620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics.
    Adler LE; Hoffer LJ; Griffith J; Waldo MC; Freedman R
    Biol Psychiatry; 1992 Oct; 32(7):607-16. PubMed ID: 1450287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.
    Martin LF; Kem WR; Freedman R
    Psychopharmacology (Berl); 2004 Jun; 174(1):54-64. PubMed ID: 15205879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory control of sensory gating in a computer model of the CA3 region of the hippocampus.
    Moxon KA; Gerhardt GA; Gulinello M; Adler LE
    Biol Cybern; 2003 Apr; 88(4):247-64. PubMed ID: 12690484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic receptor function in schizophrenia.
    Leonard S; Adams C; Breese CR; Adler LE; Bickford P; Byerley W; Coon H; Griffith JM; Miller C; Myles-Worsley M; Nagamoto HT; Rollins Y; Stevens KE; Waldo M; Freedman R
    Schizophr Bull; 1996; 22(3):431-45. PubMed ID: 8873294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia and the alpha7 nicotinic acetylcholine receptor.
    Martin LF; Freedman R
    Int Rev Neurobiol; 2007; 78():225-46. PubMed ID: 17349863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia.
    Griffith JM; O'Neill JE; Petty F; Garver D; Young D; Freedman R
    Biol Psychiatry; 1998 Jul; 44(2):98-106. PubMed ID: 9646891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients.
    Turetsky BI; Dent G; Jaeger J; Zukin SR
    Psychopharmacology (Berl); 2012 May; 221(1):39-52. PubMed ID: 22048129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.
    Potter D; Summerfelt A; Gold J; Buchanan RW
    Schizophr Bull; 2006 Oct; 32(4):692-700. PubMed ID: 16469942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of sensory gating deficits in schizophrenia.
    Freedman R; Olincy A; Ross RG; Waldo MC; Stevens KE; Adler LE; Leonard S
    Curr Psychiatry Rep; 2003 Jun; 5(2):155-61. PubMed ID: 12685995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia and nicotinic receptors.
    Freedman R; Adler LE; Bickford P; Byerley W; Coon H; Cullum CM; Griffith JM; Harris JG; Leonard S; Miller C
    Harv Rev Psychiatry; 1994; 2(4):179-92. PubMed ID: 9384901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensory gating in a computer model of the CA3 neural network of the hippocampus.
    Flach KA; Adler LE; Gerhardt GA; Miller C; Bickford P; MacGregor RJ
    Biol Psychiatry; 1996 Dec; 40(12):1230-45. PubMed ID: 8959288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropisetron improves deficits in auditory P50 suppression in schizophrenia.
    Koike K; Hashimoto K; Takai N; Shimizu E; Komatsu N; Watanabe H; Nakazato M; Okamura N; Stevens KE; Freedman R; Iyo M
    Schizophr Res; 2005 Jul; 76(1):67-72. PubMed ID: 15927799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of auditory physiology by cigarette smoking in schizophrenic patients.
    Adler LE; Hoffer LD; Wiser A; Freedman R
    Am J Psychiatry; 1993 Dec; 150(12):1856-61. PubMed ID: 8238642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
    Olincy A; Harris JG; Johnson LL; Pender V; Kongs S; Allensworth D; Ellis J; Zerbe GO; Leonard S; Stevens KE; Stevens JO; Martin L; Adler LE; Soti F; Kem WR; Freedman R
    Arch Gen Psychiatry; 2006 Jun; 63(6):630-8. PubMed ID: 16754836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.
    Zhang XY; Liu L; Liu S; Hong X; Chen DC; Xiu MH; Yang FD; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Am J Psychiatry; 2012 Sep; 169(9):974-81. PubMed ID: 22952075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism.
    Adler LE; Olincy A; Cawthra E; Hoffer M; Nagamoto HT; Amass L; Freedman R
    Neuropsychopharmacology; 2001 Jun; 24(6):671-9. PubMed ID: 11331147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice.
    Simosky JK; Stevens KE; Kem WR; Freedman R
    Biol Psychiatry; 2001 Oct; 50(7):493-500. PubMed ID: 11600102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects.
    Ghisolfi ES; Prokopiuk AS; Becker J; Ehlers JA; Belmonte-de-Abreu P; Souza DO; Lara DR
    Neuropsychopharmacology; 2002 Oct; 27(4):629-37. PubMed ID: 12377399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.